Yanli Meng
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Microbial infections and disease research
Papers in
-
- Retinoids in leukemia and cellular processes 3
- Inflammasome and immune disorders 3
- Circular RNAs in diseases 2
- Co-authors
- Yu Rebecca Miao (4 shared papers)Zhaohui Liu (5 shared papers)Lili Yu (4 shared papers)Miao Yang (1 shared paper)Ran Liu (1 shared paper)Lihong Yin (1 shared paper)Juan Liao (1 shared paper)Yuepu Pu (1 shared paper)
- Journals
- Aging (2 papers)Advanced Materials (2 papers)Annals of Palliative Medicine (1 paper)International Journal of Molecular Sciences (1 paper)Environmental Toxicology and Pharmacology (1 paper)
- Partner nations
- ChinaSingaporeSouth Korea
In The Last Decade
Yanli Meng
28 papers receiving 298 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 107
- Microbiology 23
- Molecular Biology 162
- Pulmonary and Respiratory Medicine 54
- Immunology 33
Countries citing papers authored by Yanli Meng
This map shows the geographic impact of Yanli Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Meng more than expected).
Fields of papers citing papers by Yanli Meng
This network shows the impact of papers produced by Yanli Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Meng. The network helps show where Yanli Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanli Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 64 | |
| 2 | 2020 | 29 | |
| 3 | 2017 | 21 | |
| 4 | 2021 | 21 | |
| 5 | 2019 | 20 | |
| 6 | 2018 | 19 | |
| 7 | 2011 | 19 | |
| 8 | 2017 | 14 | |
| 9 | 2014 | 14 | |
| 10 | 2012 | 11 | |
| 11 | 2021 | 10 | |
| 12 | 2024 | 9 | |
| 13 | 2016 | 9 | |
| 14 | 2015 | 9 | |
| 15 | [The clinical therapeutic effects of arsenic trioxide combined with transcatheter arterial chemoembolization in treating primary liver cancer with pulmonary metastases]. | 2012 | 7 |
| 16 | 2023 | 6 | |
| 17 | 2022 | 3 | |
| 18 | 2022 | 3 | |
| 19 | Effect of transjugular intrahepatic portosystemic shunt combined with 125I particle implantation on portal vein tumor thrombus in hepatocellular carcinoma. | 2022 | 3 |
| 20 | 2019 | 3 |
About Yanli Meng
Yanli Meng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology, Microbiology and Cancer Research, having authored 31 papers that have together received 304 indexed citations. Recurring topics across this work include Microbial infections and disease research (4 papers), Retinoids in leukemia and cellular processes (3 papers), MicroRNA in disease regulation (3 papers), Inflammasome and immune disorders (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Circular RNAs in diseases (2 papers), Pneumonia and Respiratory Infections (2 papers) and Thermal Regulation in Medicine (2 papers). The work is most often cited by research in Cancer Research (107 citations), Microbiology (23 citations), Molecular Biology (162 citations), Pulmonary and Respiratory Medicine (54 citations) and Immunology (33 citations). Yanli Meng has collaborated with scholars based in China, Singapore and South Korea. Frequent co-authors include Yu Rebecca Miao, Zhaohui Liu, Lili Yu, Miao Yang, Ran Liu, Lihong Yin, Juan Liao, Yuepu Pu, Sun Jung Kim and Jingyi Sheng. Their work appears in journals such as Aging, Advanced Materials, Annals of Palliative Medicine, International Journal of Molecular Sciences and Environmental Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.